Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Reduction to Reach Elimination of Trachoma B
NCT06289647Phase 4Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Oct 2024
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in trachoma, sponsored by University of California, San Francisco. Planned start Oct 2024; status: withdrawn.
02
Drugs
azithromycin
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT06289647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06289647.